Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Characterization of ovulation inhibition of EVE112 vaginal delivery system
2016-000115-32Phase 2Completed
- Sponsor
- Evestra
- Start
- Jan 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of etonogestrel and ethinyl estradiol in None (2 arms), sponsored by Evestra. Primary endpoint: Primary efficacy parameters. Started Jan 2016; status: completed.
02
Drugs
etonogestrelethinyl estradiol
Beyond the preview
Go deeper on 2016-000115-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000115-32.